Come up with a name for your new list and we'll add to it:
Orphagenix raised a round of funding on , . Investors include
Delaware Technology Park.
OrphageniX is a drug development company aiming to develop therapeutics for genetic diseases using advancements in "Gene Editing" technologies. OrpageniX will focus on the low volume, high margin spec…